Folate Analog Metabolic Inhibitor [EPC]

435539 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE PEMETREXED PEMETREXED DIPOTASSIUM

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	76533
1	RHEUMATOID ARTHRITIS	38354
2	ARTHRALGIA	36711
3	PAIN	35912
4	OFF LABEL USE	35746
5	FATIGUE	30160
6	NAUSEA	25268
7	JOINT SWELLING	22540
8	HEADACHE	21327
9	RASH	20809

See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	HUMAN ANTICHIMERIC ANTIBODY POSITIVE	291	0.8687
1	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE	5822	0.8299
2	RHEUMATOID FACTOR POSITIVE	4502	0.7907
3	SWOLLEN JOINT COUNT INCREASED	2400	0.7795
4	ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY	511	0.7754
5	RHEUMATIC FEVER	3138	0.7277
6	PEMPHIGUS	8930	0.7277
7	RED BLOOD CELL SEDIMENTATION RATE ABNORMAL	1653	0.7196
8	LUPUS VULGARIS	812	0.6911
9	SYNOVITIS	12275	0.6892

See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]